Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ...

Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ...

Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ...

(Hits: 173;hjemmeside tilføjet: Jun 14, 2015)

Beskrivelse:

Prolia® (denosumab), the first and only approved RANK Ligand inhibitor, has filed for approval worldwide for the treatment of postmenopausal osteoporosis.